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Abstract
Background: The interest of clinical research in aging males increased in recent years and thereby
the interest to measure health-related quality of life (HRQoL) and symptoms of aging men. The
Aging Males' Symptoms scale (AMS) became the most commonly used scale to measure HRQoL
and symptoms in aging males in many countries worldwide. The aim of this paper is to review the
current state of the instrument particularly concerning versions of the scale in different languages
in the light of the quality of the translation process.
AMS versions available: Most of the translations were performed following international
methodological recommendations for linguistic & cultural adaptation of HRQoL instruments.
Mainly the English version was used as source language for the translation into Dutch, Spanish,
Portuguese, Italian, Swedish, and Japanese (attached as additional PDF-files). Preliminary versions
that were derived only from forward translations are of secondary quality and available in Finnish,
Flemish, and Russian. It is recommended to complete the translation process for the latter
languages before using them in international studies.
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Translations in process: The AMS scale is in the process of consensus finding of two existing
French versions, and the versions in the Korean, Thai, and Indonesian languages have not yet been
completed in the translation process.
Conclusion: The AMS scale is obviously a valuable tool for assessing health related quality of life
in aging men, because it is used worldwide. It is a standardized scale according to psychometric
norms. Most of the currently available language versions were translated following international
standards for linguistic and cultural translation of quality of life scales. Assistance is offered to help
interested parties in the translation process.
Background
The interest of clinical research in aging males increased in
recent years and thereby the interest to measure health-re-
lated quality of life and symptoms of aging men.
The Aging Males' Symptoms (AMS) scale was originally
developed in Germany in 1999 [1] based on the assump-
tion that – like women during their menopausal transi-
tion – men also develop similar complaints [2]. The scale
was designed (a) to assess symptoms of aging (independ-
ent of those which are disease-related) between groups of
males under different conditions, (b) to evaluate the se-
verity of symptoms over time, and (c) to measure changes
pre- and post androgen replacement therapy [3]. It was
developed in response to the lack of fully standardized
scales to measure the severity of aging symptoms and their
impact on HRQoL in males, specifically [4,5]. A review of
reliability and validity of the scale was published else-
where [5], further details will not be discussed in this
paper.
The development of the scale started with the comparison
of more than 200 variables in more than 100 medically
well characterized males (aged over 40 years). A factorial
analysis was applied to establish the raw scale of com-
plaints or symptoms that are not particularly related to
diseases, treatment, social and other variables, but related
with aging. Statistical methods were used to identify the
dimensions of the scale and to reduce the number of
items of the raw scale. Finally, three dimensions of symp-
toms/complaints were identified in the patients group: a
psychological, a somato-vegetative, and a sexual factor
that explained 51.6% of the total variance and the number
of items of the scale could be reduced to 17. This final
scale was applied to a large representative population
sample of 992 German males in order to establish refer-
ence values for the severity of symptoms in males over 40
[1].
The scoring scheme is simple, i.e. the score increases point
by point with increasing severity of subjectively perceived
complaints in each of the 17 items (severity 1...5 points).
By checking one of 5 possible boxes of "severity" for each
of the items the respondent provides his personal percep-
tion. This can be seen in the questionnaires in the addi-
tional files linked to this publication. The composite
scores for each of the dimensions (sub-scales) is based on
adding up the scores of the items of the respective dimen-
sions. The composite score (total score) is the sum of the
dimension scores. The three dimensions, their corre-
sponding questions and the evaluation are detailed and
summarized in an attached file linked to this publication
[see Additional file 13].
The German original AMS scale was first translated and
culturally adapted into English, showing cross-cultural
equivalence [4].
Sporadic information about translations into other than
the two first languages received by the developer of the
scale (first author LAJH) led to the need to gather more
complete information about the translation process from
all key persons involved. It was agreed among the contrib-
utors to publish this review as update together with all
known language versions and to discuss quality issues.
Thus, the aim of this review paper is to present all transla-
tions we are aware of and to provide some details about
quality-relevant issues of the translation process. This
should help other international research groups to contact
key persons, to have easy access to certain language ver-
sions, and to prevent double translations.
AMS versions available
Most but not all of the translations were performed in
congruence with international methodological recom-
mendations for linguistic & cultural adaptation of HRQoL
measures [6–12] using mostly the English version as
source language to ensure cross-cultural equivalence
among countries [6]. Six steps of the translation process
are recommended: Forward translations (at least two in-
dependent translators), a consensus meeting with the co-
ordinator of the translation, a check by a bilingual expert
in the application field of the scale to evaluate the scien-
tific correctness of the wording, a backward translation, a
consensus meeting among the translators with the coordi-
nator, and finally a pretest with a few persons the test is
designed for (also called cognitive debriefing).Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/15
Page 3 of 5
(page number not for citation purposes)
The table shows the results of an inquiry among the au-
thors of different existing language versions of the AMS. It
demonstrates that most of the translations followed the
recommended process, but a few did not for various
reasons such as lack of financial sources, no need of inter-
national compatibility of results obtained with the scale
or others. Specific reasons were not inquired. However,
potential users of these incompletely adapted scales
(Finnish, Flemish, Russian language) should be encour-
aged to complete the translation and assistance of authors
of this paper is offered – if needed. The same applies for
other languages that might be needed.
As one can see from the table, the translations that fol-
lowed the recommended process involved mostly 2 for-
ward translators, a consensus meeting between these
translators with the coordinator of the translation process.
The objective of all consensus meetings is to find an ac-
ceptable solution, i.e. to make corrections, revisions, or
confirm the translation. A bilingual expert of the field, of-
ten a physician, compared the translations from the scien-
tific perspective and in a discussion with the coordinator
of the translation necessary adaptations or corrections
were made, and followed by a backward translation. A
pretest with patients was performed in all cases. The
number ranged between 5 and about 20 patients in most
countries.
Most of the translations were based on the English version
as source language. This was the first version that was pub-
lished after the standardization of the original German
AMS scale in 2000 [3]. In the translation process of the
English version we became aware at the preliminary end
of the translation process, that from the view of the North
American translators further revision was essential. A con-
sensus meeting finally agreed upon a wording that was
compatible in both cultures and also in different social
classes.
Most of the other existing versions were translated only in
the language of the mother-country. If the scale should be
applied in another country with the "same" language (e.g.
the Spanish version in Mexico, Argentine or Cuba), at
least a critical review of the translation has to be made by
a group experienced in the field of cultural adaptation. In
some cases, a new translation could be necessary that may
even influence the translation into the original language –
if compatibility is required. This is a complex process that
needs expert experience, which can be offered from the
authors of this publication or from the developer of the
scale (LAJH).
Critical distance is particularly important if results of the
AMS are intended to be pooled between different popula-
tions or regions, and less important if a study is planned
as before-after-treatment-comparison in one country with
only one language. The latter applies only if the linguistic/
cultural adaptation process considered different social
classes and regions with slight language differences, which
is standard in experienced groups.
For completeness, all AMS versions are attached as addi-
tional files in PDF-format (Adobe Acrobat), even the pre-
liminary language versions that obviously did not follow
the "state-of-the-art" translation process (Finnish, Russian
and Flemish language) or are not completed (Korean lan-
guage). The majority of language versions, however, fol-
lowed the same, i.e. internationally recommended,
Table 1: Review of AMS scales available in different languages Characteristic of linguistic & cultural translation
Internationally recommended translations Incomplete translations
German English Swedish Dutch Spanish Portuguese Italian Japanese Korean* Finnish Russian Flemish
Source language Original German English English English English English English English English English English
F o r w a r d  t r a n s l a t i o n s :  n u m b e r n . a . 3222 2 222211
Forward translation: consensus 
meeting
n.a. Yes Yes Yes Yes Yes Yes Yes Yes Yes No No
Bilingual (medical) expert n.a. Yes Yes Yes Yes Yes Yes Yes Yes Yes No No
Backward translation n.a. Yes Yes Yes Yes Yes Yes Yes Not yet No No No
Backward translation: consen-
sus meeting
n.a. Yes Yes Yes Yes Yes Yes Yes Not yet n.a. n.a. n.a.
Pretest with patients (cognitive 
debriefing)
n.a. Yes (20) Yes (20) Yes (5) Yes (5) Yes (20) Yes (20) Yes (5) Yes(25) Yes No Yes
Developer of the scale involved 
in the translation process
n.a. Yes Yes Yes Yes Yes Yes Yes Yes No No No
Test-retest (number) Yes 
(102)
Yes (92) Yes (48) No Yes (30) Yes (40) Yes (40) No Yes (25) Yes (89/
208)
No No
Clinical study with AMS Yes No? Planned Yes Yes Planned Planned Planned Yes? Yes No (Yes)
n.a. = not applicable * = to be completed in due courseHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/15
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complex methodology of language adaptation. For this
reason, we can assume that they have linguistic and cul-
tural equivalence, although different groups did the trans-
lation work. We will further try to facilitate this process in
other languages if requested.
For access to the original scales in 12 different languages,
please see additional files linked to this publication:
• Additional file 1: German version of the AMS
• Additional file 2: English version of the AMS
• Additional file 3: Swedish version of the AMS
• Additional file 4: Finnish version of the AMS
• Additional file 5: Dutch version of the AMS
• Additional file 6: Flemish version of the AMS
• Additional file 7: Spanish version of the AMS
• Additional file 8: Portuguese version of the AMS
• Additional file 9: Italian version of the AMS
• Additional file 10: Russian version of the AMS
• Additional file 11: Japanese version of the AMS
• Additional file 12: Korean version of the AMS
It should be stressed that persons who are interested in ap-
plying the AMS scale in their research can download the
appropriate language version and use it without any for-
mal permission. However, it would be important to keep
an overview who is using the scale and for what reason.
Therefore, an information should be sent to the developer
and copyright holder of this scale (LAJH). In return, all in-
formation on the scale that became known in between
will be made available.
Translations in progress
The AMS scale is in the process of translation in KOREA
(attached as PDF-File of the forward translation), in THAI-
LAND (personal communication: Somboon Leungwat-
tanakij, Division of Urology, Ramathibodi Hospital,
Bangkok, Thailand), and in INDONESIA (personal com-
munication: Dr. Akmal Taher, Indonesia). In addition,
there is a consensus process almost completed to establish
a reference version of two existing French AMS scales. The
harmonized French version will be published soon and
will be available on request.
Conclusions
The AMS scale is obviously a valuable tool for assessing
health related quality of life in aging men, because it is
used worldwide. It is a standardized scale according to
psychometric norms. Most of the currently available lan-
guage versions were translated following international
standards for linguistic and cultural translation of quality
of life scales. Assistance is offered to help interested parties
in the translation process.
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